EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens

Tali S Skipper iD, Kristie-Ann Dickson iD, Christopher E Denes iD, Matthew A Waller iD, Tian Y Du iD, G Gregory Neely iD, Nikola A Bowden iD, Alen Faiz iD, Deborah J Marsh iD

Cellular Oncology · 2025

DOI: 10.1007/s13402-025-01102-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Oncology, 2025. Verfasst von Tali S Skipper und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. tali.s.skipper@st…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Gene Knockout Techniques, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Technology Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding genetic dependencies in cancer is key to identifying novel actionable drug targets to advance precision medicine. Whole-genome CRISPR-knockout library screening methods have facilitated this goal. Pooled libraries of single guide RNAs (sgRNAs) targeting over 90% of the annotated protein coding genome are used to induce gene knockouts in pre-clinical cancer models. Novel genes of interest are identified by evaluating sgRNA dropout or enrichment following selection pressure application. This method is particularly beneficial for researching cancers where effective treatment strategies are limited. One example of a commonly chemoresistant cancer, particularly at relapse, is the low survival malignancy epithelial ovarian cancer (EOC), made up of multiple histotypes with distinct molecular profiles. CRISPR-knockout library screens in pre-clinical EOC models have demonstrated the ability to predict biomarkers of treatment response, identify targets synergistic with standard-of-care chemotherapy, and determine novel actionable targets which are synthetic lethal with cancer-associated mutations. Robust experimental design of CRISPR-knockout library screens, including the selection of strong pre-clinical cell line models, allows for meaningful conclusions to be made. We discuss essential design criteria for the use of CRISPR-knockout library screens to discover genetic dependencies in cancer and draw attention to discoveries with translational potential for EOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDrug Resistance, NeoplasmGene Knockout TechniquesCRISPR-Cas SystemsGene LibraryClustered Regularly Interspaced Short Palindromic RepeatsHumansFemale

Autor:innen und Institutionen

  • Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. tali.s.skipper@student.uts.edu.au.
  • Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
  • Dr. John and Anne Chong Lab for Functional Genomics, Charles Perkins Centre, School of Life and Environmental Sciences, University of Sydney, Camperdown, NSW, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia.
  • Respiratory Bioinformatics and Molecular Biology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia.
  • Translational Oncology Group, School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia. deborah.marsh@uts.edu.au.

ORCID-Profile: Tali S Skipper, Kristie-Ann Dickson, Christopher E Denes, Matthew A Waller, Tian Y Du, G Gregory Neely, Nikola A Bowden, Alen Faiz, Deborah J Marsh

Förderung

  • University of Technology Sydney

Zitieren

APA

Skipper, T. S., Dickson, K. A., Denes, C. E., Waller, M. A., Du, T. Y., Neely, G. G., Bowden, N. A., Faiz, A., & Marsh, D. J. (2025). Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens. Cellular Oncology. https://doi.org/10.1007/s13402-025-01102-4

Vancouver

Skipper TS, Dickson KA, Denes CE, Waller MA, Du TY, Neely GG, et al. Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens. Cellular Oncology. 2025. doi:10.1007/s13402-025-01102-4

BibTeX
@article{Skipper2025,
  author = {Skipper, Tali S and Dickson, Kristie-Ann and Denes, Christopher E and Waller, Matthew A and Du, Tian Y and Neely, G Gregory and Bowden, Nikola A and Faiz, Alen and Marsh, Deborah J},
  title = {Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-025-01102-4}
}
Kostenlos starten →